Morphine/oxycodone

Drug Profile

Morphine/oxycodone

Alternative Names: MoxDuo; MoxDuo® CR; MoxDuo® IV; Oxycodone/morphine; Q 8003; Q 8011; Q8012

Latest Information Update: 30 Oct 2014

Price : $50

At a glance

  • Originator QRxPharma
  • Class Morphinans; Opioid analgesics; Small molecules
  • Mechanism of Action Opioid delta receptor agonists; Opioid kappa receptor agonists; Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Pain; Postoperative pain

Most Recent Events

  • 14 Aug 2014 Discontinued - Phase-II for Postoperative pain in Australia (IV)
  • 14 Aug 2014 Discontinued - Phase-II for Postoperative pain in USA (IV)
  • 14 Aug 2014 Discontinued - Phase-II for Postoperative pain in Germany (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top